• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    2.31 Down 0.16(6.48%) Jun 24, 4:00PM EDT
    Prev Close:2.47
    Open:2.35
    Bid:0.22 x 3300
    Ask:N/A
    1y Target Est:7.67
    Beta:1.34776
    Earnings Date:Aug 2 - Aug 8 (Est.)
    Day's Range:2.27 - 2.40
    52wk Range:1.88 - 3.68
    Volume:1,031,633
    Avg Vol (3m):405,034
    Market Cap:212.85M
    P/E (ttm):N/A
    EPS (ttm):-0.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RIGL

    Comparison

    Symbol% ChgMkt Cap
    RIGLDown 6.48%212.85M
    AMGNDown 3.82%110.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.58
    Quarterly EPS Est (Jun-16) :-0.19
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel and targeted drug candidates in the therapeutic areas of immunology, oncology, and immuno-oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback